Press & media
Press and media contact: Derek Butler, Chair
For the latest Press Releases from MRSA Action UK visit the Opinion Formers Website
5 News - Global warning over resistance of antibiotics to superbugs
May 19, 2016
If the world doesn't take action now, superbugs will kill someone every three seconds within a generation. That's the stark warning from a global study into antibiotics, which says we're overusing them and failing to develop enough new ones. The report says in future, basic procedures we take for granted could become too dangerous to carry out.
The battle against drug resistant infection
May 19, 2016
The battle against infections that are resistant to drugs has been described as "big a risk as terrorism", according to a new report. The Review on Antimicrobial Resistance says superbugs will kill someone every three seconds by 2050 unless the world acts now. Joanna Gosling spoke to Professor Laura Piddock, who advised on the report, Yvonne Smith, who lost her father to a superbug infection, Derek Butler, from charity MRSA Action UK, Sharon Brenan, a transplant patient and health journalist and Professor Paul Cosford from Public Health England. More...
MRSA Action UK respond to media on NICE antimicrobial stewardship and plans to penalise GPS who 'over-prescribe'
18 August 2015
The use of antibiotics has risen steadily over recent years with 41.6 million NHS prescriptions issued last year in England alone at a cost of £192m. Nine out of ten GPs say they feel pressurised to issue the prescriptions and 97 per cent of patients who ask for them are prescribed them. Between 20 and 30 per cent of antibiotics currently prescribed by the NHS are unlikely to benefit patients, for example because they are suffering from a throat virus – one of the most common reasons for taking a course of antibiotics.
Derek Butler, Chair of MRSA Action UK was interviewed by Channel 5 News and on BBC Radio London giving our viewpoint and spoke about the impact of antimicrobial resistance on families in the reports.
MRSA Action UK is calling for education for both prescribers and the public. In its response to the consultation on the NICE quality statement on antimicrobial stewardship the charity asked for the provision of antimicrobial pharmacists and improved diagnostic tools to speed up the process of identifying organisms that cause infections. There is, we feel, an emphasis needed on prescribing the correct antimicrobial at the right time. Without the training and tools of the trade this is a challenge for prescribers. Derek advised that we have to preserve these powerful drugs or we would be facing a future where the simplist of infection will be untreatable, and return to the pre-antibiotic era. View our press release for more information
Dangers of the doctors and nurses who still don't wash their hands: MP who lost her father to superbug vows to clean up NH
By LUCY ELKINS FOR THE DAILY MAIL
PUBLISHED: 23:20, 15 June 2015 | UPDATED: 00:35, 16 June 2015
To those who watched the General Election results come in, Andrea Jenkyns is the woman who provided 2015's 'Portillo moment' as she unexpectedly unseated the former shadow chancellor, Ed Balls, and became the new Conservative MP for Morley and Outwood.
As she stood on the podium smiling, one person played heavily on her mind - her father Clifford. It was largely his premature death from a hospital-acquired infection in 2011 that prompted the former music teacher and singer to move into politics.
Clifford had mesothelioma, lung cancer, brought on by exposure to asbestos.
'He was a lorry driver in the Fifties and Sixties and was transporting asbestos sheets everywhere - people weren't aware of the risks back then,' says Andrea. But the prognosis was good as the cancer had been spotted at an early stage. Clifford, a former boxer, then 73, was told that with surgery to remove it he could expect to live another ten to 20 years. His only symptom was slight breathlessness.
Tragically, however, he would be dead within four months - not from the cancer, but from an infection he picked up during a routine procedure in hospital.
Losing her father so unexpectedly and so needlessly had a big effect on Andrea, now 40. 'He was my hero, he was a fantastic dad, such a good man,' she says quietly.
'He wasn't bitter and we aren't bitter as a family, but it's not easy - his death was entirely unnecessary.'
Clifford went into Pinderfields Hospital in Wakefield in July 2011 to have fluid drained from his lung. It had collected as a result of the cancer and was hampering his breathing. His family was told it would be a quick procedure that would take at most 20 minutes. In fact it took two and a half hours.
'When he went in, there was a consultant overseeing some trainees and they practised taking the drainage tube out of Dad and putting it back in,' says Andrea. 'Dad - who had only had local anaesthetic - said he saw blood spurting out, but he was a tough man and wouldn't admit if it was hurting.
'What we found out later was that they did the procedure in a room where the cleaners kept their mop buckets; the door was kept open all the time and next door were people who had infections such as MRSA and clostridium difficile.'
After the procedure, Clifford went straight home. But within 24 hours it was apparent that he was not right; the wound site smelled and he seemed hot and unwell.
The next day Andrea's sister took him back to hospital, where tests showed he had MRSA.
As the infection took hold, Andrea witnessed her once strong father transform into a shadow of his former self. At times he was halluncinating and barely compos mentis. His weight plummeted to 7st, extremely frail for his 5ft 9in frame.
Despite the fact that her father was being treated for hospital-acquired infection, Andrea could only watch in horror as some of the staff didn't observe simple hygiene precautions.
They did the procedure in a room where the cleaners kept their mop buckets; the door was kept open all the time and next door were people who had infections 'Many times we had doctors and nurses coming in and out who didn't wash their hands,' she says. 'When you have MRSA they put antibacterial cream up your nose.' This is because the warm moist environment in the nose makes it a hot spot for MRSA.
'On one occasion a nurse walked in, put a bit on her bare finger shoved it up Dad's nose and walked back out without washing her hands. 'When I followed her back to the nurses' station and asked her why she hadn't washed her hands, I was met with blank looks.'
For four months Clifford was shuttled between home and hospital, but the infection proved resistant to all the antibiotics tried on him and he died at home in November 2011 with his wife Valerie present. 'I had just popped home to get some clothes when Mum called to say Dad had died,' recalls Andrea.
'I went straight back. He was on the floor - Mum had tried to do CPR - and I held onto his tummy, it was the last piece of warmth to him. I was trying to hang onto the last bit of life in him, I didn't want him to go.'
The post-mortem confirmed Clifford had died of MRSA acquired in hospital. MRSA, or meticillin-resistant staphylococcus aureus, is caused by a type of bacterium, staphylococcus, which is resistant to many antibiotics - around 1 per cent of us carry these bacteria on our skin.
If the bacteria get into the bloodstream - and it takes only a tiny nick in the skin for this to happen - they can be very difficult to treat.
In 10-20 per cent of cases they prove fatal, as the bacteria can cause blood poisoning. While MRSA infection rates have dropped more than 70 per cent since their peak a decade ago, figures published last week by Public Health England show that cases are slowly pushing upwards again. The number of cases reported between January and March this year has increased by just over 9 per cent compared with the same period last year.
Derek Butler, of the charity MRSA Action UK, says: 'We have done very well at getting infection rates down over the past few years but there is a fear that people are beginning to take their eye off the ball.'
And it's not just MRSA. Cases of clostridium difficile, another infection that can commonly be acquired in hospitals and other healthcare settings, such as nursing homes, is also on the rise. C.diff is a bacterium that causes infectious diarrhoea and is spread in the faeces of an infected person.
The bacteria produce spores that can survive on surfaces and are then transferred by people touching that surface and passing on the bug.
C.diff can prove deadly to someone whose immune defences are low, such as an elderly person, or someone taking broad spectrum antibiotics, as these also wipe out many of the helpful bacteria that play a part in your immune system, explains Dr Tony Worthington, a clinical microbiologist at Aston University.
From January to March 2015, the number of C.diff cases rose by 12 per cent, from 3,006 to 3,888 compared with the same point last year; the number of cases reported by hospital trusts has increased by 17 per cent again compared with the same period last year.
So what is behind the rise? According to Dr David Jenkins, consultant medical microbiologist and lead infection prevention doctor, University Hospitals of Leicester NHS Trust, hygiene is the key.
Andrea wants to see monthly posters displayed in hospitals, showing the faces of those who have died of a hospital-acquired infection. 'Keeping these infections down involves three things: good hand hygiene, good environmental hygiene (such as keeping wards clean) and the proper use of antibiotics,' he says. 'However, people move on and those healthcare professionals who were around in 2006 when infections were at their peak have in many cases gone.
'So in some cases we are now having to remind people of the importance of good hygiene. Many people - even some healthcare professionals - think infection control is done and dusted and MRSA and C.diff have gone away. But they haven't - and in my opinion these are just the warm-up acts to the multi-drug resistant bugs we could face in the future.'
Already he says some hospitals are having difficulties with the number of drug-resistant E.coli cases.
Last year, the National Institute for Health and Care Excellence called on doctors and nurses to redouble their hygiene effort to bring down 'unacceptable and avoidable infection rates'.
It emphasised one in 16 people treated by the NHS still acquires an infection of some kind, highlighting hygiene - and basic hand washing - as one key to reducing figures.
From what she has seen, Andrea Jenkyns believes the message is still not getting through.
Following her father's death Andrea joined MRSA Action UK. She and her mother became trustees and Andrea became the regional representative, getting involved with patient-led inspections on behalf of the Department of Health.
A year after her father died she went to a health conference to give a talk about the importance of hand hygiene to 400 nurses and doctors.
When she asked how many believed hand washing could save lives, she was 'shocked' by how few raised their hands. It helped fuel her determination to get more involved in politics - she was already a county councillor when her father died.
'After what happened I thought the only way to make a difference is to be on the inside and policy making,' she says.
She fears there is still much work to be done. In the past fortnight she has been visiting an elderly constituent with C.diff whose family contacted her about their concerns about hygiene in a hospital.
'They told me a temporary nurse walked into a lady's room and plugged her phone charger into a socket - even though the lady had C.diff.'
Andrea would like to see less tolerance of those healthcare workers and hospital visitors who don't wash their hands.
'Handwashing must be part of training and if people don't do it they should be subject to a hospital's disciplinary procedures,' she says. 'In food factories people wash their hands all the time - and in hospital we are dealing with people's lives.
She also wants to see monthly posters displayed in hospitals, showing the faces of those who have died of a hospital-acquired infection.
'It's to humanise the statistics - to show these people who died needlessly were someone's dad, someone's sister, someone's daughter. That could help get the message across - that washing hands saves lives.' Read the full article on the Daily Mail website
BBC Radio 4 - The Report
7 May 2015 - 8.00pm
Why drug resistance is now regarded by the UK government as one of the most severe threats to public safety. Peter Marshall reports.
Derek Butler and Maria Cann join the debate on BBC Radio 4
MRSA Action UK proposal to the government
Healthcare Infections A Manifesto 2015
29 April 2015
With growing problems with antimicrobial resistance, reductions in Clostridium difficile disease stalling at around 20,000 recorded cases a year, and 14,000 Staph bloodstream infections a year – the micro-organism involved in the evolution of MRSA - MRSA Action UK calls for cross-party support in "Healthcare Infections a Manifesto 2015"
The antibiotics apocalypse: It's frightening how many Britons are dying from bugs that have grown resistant from overuse of antibiotics. Now a new mutant breed's spreading that NOTHING can treat
Bacteria around the world are acquiring new ways to beat our antibiotics. These mutant bacteria are known to have killed more than 20 people in UK. They have infected hundreds, if not thousands - no one knows the true toll
By John Naish for The Daily Mail PUBLISHED: 01:23, 13 March 2015 | UPDATED: 10:23, 13 March 2015
Albert Alexander, a 43-year-old Oxford policeman, made world history in March 1941. While pruning roses, he scratched the side of his mouth.
Two strains of bacteria - staphylococcus and streptococcus - invaded the wound, producing lethal abscesses on his eye, face and lungs.
The threat of such agonising infections haunted everyone in those days. Since the dawn of humankind, people had regularly been killed by bacteria from minor wounds, or through infections from childbirth or surgery.
There were no effective treatments for pneumonia, gonorrhoea or rheumatic fever. Hospitals were full of people with blood poisoning. Doctors could do little for them.
But PC Alexander was the first patient ever to receive the wonder-drug penicillin. Within days of the first shot, his temperature dropped and his appetite returned. Stocks of the new antibiotic were minuscule, however. Doctors at the Radcliffe Infirmary desperately recycled penicillin from Alexander's urine to keep it in his bloodstream, but after five days all supply ran out. The infection raged again, killing him.
Today we are being thrown back to the world of PC Alexander, where an everyday scratch could spell death.
However, this is not because we don't have enough antibiotics. The opposite is the case. We are using far too many of them - and unnecessarily so. Thus, by our over-prescription, we teach ordinary bugs to become antibiotic-immune superbugs.
Bacteria around the world are rapidly acquiring an alarming new way to beat our best antibiotics, as if arming for a doomsday showdown with humanity.
These mutant bacteria, which carry a fragment of DNA called NDM-1, are known to have killed more than 20 people in Britain and infected hundreds, if not thousands. No one knows the true tol
Antibiotic-resistant germs first made headlines in the Eighties with MRSA. This was a new strain of the Staphylococcus aureus bacteria that normally lives harmlessly on the skin and in the noses of one in three of us.
The emerging strain of Staphylococcus had learned to shrug off strong antibiotics, most notably meticillin - hence its name, Meticillin Resistant Staphlococcus Aureus. The official annual death toll in England from MRSA peaked at 1,652 in 2006. Most victims were infected while in hospital.
Susan Fallon, of Newcastle in Staffordshire, knows only too sadly the terrible toll of MRSA. She lost her 17-year-old daughter, Sammie, to it in 2008. Sammie had been admitted to University Hospital of North Staffordshire for blood tests on a suspected viral infection.
A needle was pushed into her hip to take a bone marrow sample.
Three days later, while still in hospital, Sammie complained that her hip had swelled at the needle site. "Within a week, the swelling had got worse," says Susan. "Three days later a nurse gave me a leaflet about MRSA. I had vaguely heard of it. My mother, who had been a nurse, was with me. I saw from Mum's face that was bad."
The infection rapidly invaded Sammie's lungs and other vital organs, beating the hospital's strongest antibiotics. She began to have fits, then lost consciousness. Her kidneys failed and she was put on dialysis. Two days later she died.
The death certificate recorded the cause of death as multi-organ failure, MRSA, septicaemia and a viral infection. "I was advised to sue the hospital, but after three years, the solicitor said that we couldn't identify which nurse had put the needle into her hip and we couldn't prove our case.
"Sammie was screened for MRSA on admission and found free of the bacteria," Susan adds. "But we can't prove legally how she got it. The hospital has never apologised."
Liz Rix, the trust's Chief Nurse, told the Mail: "In the seven years since Miss Fallon's care, the trust has improved infection-prevention procedures to radically reduce the number of MRSA bacteraemia contracted by patients in our hospitals from 70 in 2008 to just five in 2014."
Across the NHS, improved infection control has significantly cut hospital deaths from MRSA, which is spread by touch. In 2012, MRSA was recorded 292 times on English death certificates - 1,360 down from the peak. However, that hopeful news is quashed by the fact that many other antibiotic-resistant bacteria are on the march.
Last October, a report from Public Health England warned that overall, infections by such bacteria had increased between 2010 and 2013. For example, infections caused by E.coli that were resistant to key antibiotics had risen by more than 10 per cent. Drug-resistant versions of other infections, such as pneumonia and gonorrhoea, are also growing.
Meanwhile, antibiotic prescribing by GPs and hospital medics has increased by 6 per cent. More than 40 million such prescriptions are believed to be written a year by GPs. Often these are for colds, coughs and flu - caused mostly by viruses, which antibiotics cannot treat. GPs claim that they often feel under pressure to prescribe from patients.
Mark Lloyd Davies, the chair of the antibiotic network at the Association of British Pharmaceutical Industries
Our society is hooked on the fading promise of these wonder-tablets, even if they won't work. Too often, doctors are happy to oblige, just to clear their consulting rooms. Antibiotics certainly have had a wondrous effect. Largely thanks to them, between 1944 and 1972, our life expectancy jumped by eight years. I owe my own life to them. Aged six months, I contracted double pneumonia. This was in 1964, less than two decades after the medicines became available. The drug that saved me back then would most likely not work nowadays due to the resistance bacteria has built over the years. Our magic swords have been beaten blunt by overuse.
The authorities have tried repeatedly to stop family doctors worsening the crisis.
In 2009, the European Centre of Disease Prevention and Control wrote to every GP in Britain, telling them to stop prescribing antibiotics unnecessarily. Since then, campaign after campaign has been mounted to persuade GPs to kick their prescription habit, by organisations such as the Royal College of General Practitioners as well as the nurses' and pharmacists' professional bodies. All have failed. Now the medicines watchdog, NICE, is proposing that we bribe doctors to change their ways.
NDM-1 (pictured) is an enzyme - a mutant piece of DNA - that turns ordinary bacteria into lethal bugs which our best bullets bounce off. It is also immune to most other antibiotics, including penicillins
Last month, it proposed that GPs be paid extra for not doling out antibiotics unnecessarily. Antibiotics are not a human invention. Nature used them for millennia before we learned the trick in 1928, after Alexander Fleming noticed how a green mould in his lab was killing bacteria on a specimen dish.
But in the Fifties, humans began carpet-bombing the globe with industrial antibiotics. Suddenly, this accelerated the evolutionary battle into lightning chemical warfare.
In the process, something unheralded and alarming has been happening to the bacteria surrounding us, warns Timothy Walsh, the professor of medical microbiology and antimicrobial resistance at Cardiff University.
Under the onslaught of medical antibiotics, "the bacterias' structures have become unstable - sloppier and much more reactive to new bits of DNA about them", he says. "These microbes are responding to the environmental stress that our antibiotics create for them."
It is as though they are trying desperate gambits to retaliate. The most dangerous mutation to emerge so far sounds more like something from an episode of Doctor Who than a medical journal.
Professor Walsh explains that the latest bacterial tactic involves NDM-1. This is an enzyme - a mutant piece of DNA - that turns ordinary bacteria into lethal bugs which our best bullets bounce off.
The enzyme is spreading from one strain of bacteria to another, giving every new host the same drug-defying powers. NDM-1 originated in Asia. It is now swiftly colonising Britain and the rest of the Western world.
Public Health England says that the number of laboratory-confirmed cases of bacteria carrying NDM-1 has risen from just five in 2006, to more than 600 in 2013.
The bacteria known already to carry it include mutant versions of common and usually harmless gut bugs - Klebsiella and E.coli.
According to Public Health England, the NDM-1 enzyme has made them immune to our "last resort" antibiotics - called carbapenems - which medics use to beat infections when other antibiotics have failed.
NDM-1 breaks down these drugs, rendering them useless. It is also immune to most other antibiotics, including penicillins. Experts at the U.S. Centres for Disease Control say that it contributes to the death of up to half of patients who become infected.
Earlier this month, it was revealed that 16 people have died in the Central Manchester University Hospitals NHS trust area in the past four years after contracting one of these mutant strains - Klebsiella pneumoniae carbapenemase. Another died at Wolverhampton's New Cross Hospital.
Hundreds of other patients are believed to have been infected. Central Manchester says all the patients who died had been seriously ill with conditions such as diabetes, cancer, kidney problems or transplant rejection.
Professor Walsh is the man who first identified NDM-1, in 2000. He found it in samples from India. As is his habit, he named it after the city where it originated. It is called New Delhi metallo-B-lactamase 1.
This is one of the reasons that Walsh is barred from India. "Their government objected to what they see as an insult to their capital city," he says.
The other reason for the ban is that his work threatens one of India's rapidly growing profitable industries - medical tourism.
Every year, thousands of Britons travel there for cheap operations, often cosmetic surgery, but also organ transplants that NHS surgeons have declared too hazardous to perform. Hospitals on the subcontinent may charge only one-fifth of what a UK private hospital asks.
However, India effectively acts as a vast petri dish for growing new antibiotic-resistant superbugs. Poor sanitation and healthcare hygiene spread bacteria rapidly. Moreover, antibiotics can be bought cheaply, easily and frivolously at chemists on the subcontinent.
Professor Walsh says his recent study of 2,000 people in Karachi, Pakistan, has shown that 28 per cent carry E.coli with the NDM-1 DNA. From this, he estimates that across the whole subcontinent, 250 million people already harbour it.
"Many people travelling to India for operations must be contracting NDM-1 infections, says the professor. They then bring NDM-1 back to Britain.
"This combination of threats dwarfs the problem of British GPs over-prescribing antibiotics," he claims. He adds that, due to lack of surveillance, "no one has a clue how many people are bringing this into the UK or what the prevalence of NDM-1 is here."
A coroner's inquest in Swansea last year has highlighted one particularly tragic case involving medical tourism to India. The inquest heard how antibiotic-resistant E.coli killed a baby born 15 weeks premature whose mother had undergone IVF treatment in India.
The bacteria also killed the baby in the adjacent hospital incubator at Singleton Hospital, Swansea, who had been born 14 weeks premature.
The mother of the first child, named only as Baby A1, was unaware she had picked up the particularly deadly mutated form of E.coli, although it was mentioned in her medical notes from India. The inquest last July heard that the notes were not sent to staff in Swansea.
As a result, rigorous infection control procedures were not instituted and the infection passed to the second baby, Hope Erin Evans, from Aberdare, who also succumbed. She was only five days old.
NDM-1 is not going to go away, says Professor Walsh. "Once bacteria have the NDM-1 enzyme, they can't get rid of it without dying because it has become an essential part of their biology. They are held hostage by it," he explains.
Meanwhile, Britain is spearheading efforts to produce more powerful new antibiotics. Prime Minister David Cameron has launched a commission to tackle antibiotic resistance. Part of its remit is to create better incentives for the pharmaceutical industry and academic researchers to develop new drugs.
Professor Walsh fears this is naive. "There is no point producing new drugs if we don't have global patent safeguards to protect them from overuse," he says.
The answer, suggests Mark Lloyd Davies, the chair of the antibiotic network at the Association of British Pharmaceutical Industries, is to protect a new generation of antibiotics by stockpiling them in a secure place.
"There are already systems like this in place for drugs such as vaccines," he says. "Good stewardship of new antibiotics is absolutely the key by keeping them under strict Government control."
Certainly, if sense is to prevail, we must use far fewer antibiotics, in far more targeted ways. Even if we have to lock them away.
As in the era before antibiotics, hygiene must again become king. And patients must see the sense of leaving their GPs without a prescription in their pockets.
The alternative is no antibiotics at all - and a return to the days when a scratch from a rose can bring agonising death.
MRSA Action UK comments on reactions to the new NICE guideline on antimicrobial prescribing
Wednesday 18 February 2015
GPs must help us do more to reduce superbugs, skills and training not cash incentives are needed
Derek Butler, Chair of MRSA Action UK appeared on ITN and Channel 5 News highlighting the need for GPs to focus on patient outcomes in the prescribing of antibiotics.
MRSA Action UK supported the development of the NICE guideline on the prevention and control of healthcare associated infections, and welcomed the introduction of the quality statement on the requirement of judicious antimicrobial prescribing.
As people who have been directly affected we welcome the opportunity to be stakeholders with NICE in developing the draft guidance. We would emphasise however, that the prescribing of antibiotics is, and will always be, the responsibility of the prescribing practitioner, whether that is in or outside of hospital. The guideline must be viewed as a minimum requirement, and colleagues should be encouraged to focus on judicious prescribing.
MRSA Action UK does not however support or agree with Professor Mark Baker's comment in the media that NICE is considering bringing antibiotics into the existing bonus scheme for GP's not to prescribe these drugs, this is both wrong and immoral as some patients will always require treatment for infections, it is the clinical need that needs to be ascertained and the correct diagnosis determined and appropriate treatment given that needs to be correct.
Making a decision about whether a respiratory illness is bacterial or viral is not always easy in someone who is more vulnerable. For example, some throat and ear infections are due to bacteria, and not viruses, and some people with a cough and breathlessness are actually developing pneumonia, which may be bacterial and antibiotics would be essential.
While tests such as throat swabs or sputum (mucus) samples can help with diagnosis, such investigations take time, so skill needs to be deployed to make these decisions. We would have to say that giving bonuses is not necessarily a prerequisite to a GP or any prescribers' ability to be able to do this. So financial incentives should not be the focus here, patient outcomes must always be the main focus of any prescriber; the need is for training and better information in this field of medicine.
We look forward to working with NICE.
ITN News 8:22pm, Wed 2 Jul 2014PM: Superbugs risk medicine 'returning to the dark ages' PM calls for development of new antibiotics
David Cameron has warned we risk returning to the "dark ages" unless drugs firms develop new treatments with 70 per cent of medications now resisting at least one 'superbug'.
Catherine Jones reports that for Derek Butler the risks can't be overstated, MRSA claimed the lives of his grandfather, his uncle and his stepfather, he said "We have had these warnings before, we are now at the precipice we now need to deal with this situation"
In England 35 million antibiotics are prescribed a year, 70% of bacteria are resistant to at least one antibiotic, and it is 25 years since any new class of antibiotic has become available.
Urgent calls for new antibiotics as the threat of untreatable infections looms - Channel 5 News 2 July 2014
"If we don't sort this and get new antibiotics, we will see the end of modern medicine as we know it, cancer therapies, routine operations like replacement hips or caesarean sections, people dying young with infections in their hearts, even if we go back to the very old days, people dying of cuts" - Dr Sally Davies, Chief Medical Officer for England
Derek Butler, who lost three relatives to the antibiotic resistant bug MRSA, tells Peter Lane "We are at a precipice, we need global action". Watch Peter Lane's full report here: